ArticleChinese medical journal2026

Development of the model for predicting the efficacy of bevacizumab and prognosis in ovarian cancer using deep learning-based pathomics signatures.

Han Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.